US Expands Forced-Labor Import Ban to 187 Chinese Companies

The United States has broadened its forced-labor import ban to cover 187 Chinese companies, up from 144, with the new restrictions taking effect from Monday. Goods produced by the newly added firms are now presumed to have been made with forced labor and are barred from entering the US market, unless individual importers can successfully prove otherwise on a case-by-case basis.

The expansion, carried out by the US Department of Homeland Security, builds on a list first created in June 2022 under legislation passed in late 2021. Washington says the affected companies source materials from China's Xinjiang region or take part in state-run labor programs there. The new additions span the electronics, pharmaceutical and cotton sectors.

China's commerce ministry rejected the move as a "typical case of economic coercion," said the allegations lack any basis, and promised to take "necessary measures" to protect Chinese firms. The ministry also questioned the timing: the announcement came one day after Chinese Vice Premier He Lifeng held a video call with US Treasury Secretary Scott Bessent and US Trade Representative Jamieson Greer.

The dispute sits against a backdrop of planned high-level diplomacy. President Donald Trump has said Chinese President Xi Jinping will visit the White House in September, a meeting that now carries additional weight as both sides signal their positions on trade.

Advertisement

Why the UFLPA List Keeps Growing and What Beijing May Do Next

Why the Forced-Labor List Keeps Expanding

The jump from 144 to 187 companies shows that the United States is using the law passed in late 2021, commonly known as the Uyghur Forced Labor Prevention Act (UFLPA), as a standing enforcement tool rather than a one-off measure. The original list, operational since June 2022, targeted cotton and polysilicon supply chains linked to Xinjiang. Adding electronics and pharmaceutical firms suggests the review now reaches deeper into China's industrial base.

Under the law's logic, any goods from listed entities are presumed tainted. The burden shifts to importers to demonstrate that their shipments were made without forced labor. That presumption, not the underlying allegations alone, is what makes the list commercially painful: it disrupts established supply chains and forces US buyers to prove a negative, which is slow and expensive for complex electronics and pharma sourcing.

What Beijing's "Necessary Measures" Could Involve

The commerce ministry's statement gives no specifics. Based on China's past responses to US trade actions, plausible reactions include retaliatory tariffs on US goods, export controls on critical materials, or a challenge at the WTO. None of these have been announced, and the ministry's wording may also be aimed at domestic audiences ahead of any negotiation. This part of the analysis is interpretation, not confirmed fact.

Timing Ahead of the Trump-Xi Meeting

Beijing called out the timing deliberately: the list was published a day after He Lifeng's call with Bessent and Greer. The sequence suggests the US is pressing its trade leverage while keeping diplomatic channels open. The announced September Trump-Xi meeting is now the key event to watch — it could either freeze the escalation or produce a narrow deal that pauses further additions.

Advertisement

Who Gains and Who Loses

The immediate losers are the 43 newly listed Chinese companies, which lose US market access unless their customers can rebut the presumption. US importers in affected sectors face higher compliance costs and possible shipment delays. The likely winners are suppliers not on the list, including producers outside China, who can absorb orders redirected away from listed firms.

What Importers and Buyers Should Check Before the September Summit

Who this matters for: US importers, multinational supply-chain teams, and buyers of electronics, pharmaceuticals and cotton linked to China.

  • Treat any shipment from the 187 listed companies as blocked as of Monday unless you can document that the goods were produced without forced labor; the rebuttal process is case-by-case and slow.
  • Re-screen suppliers now: the list grew from 144 to 187 companies, so an audit conducted before this update is already out of date, especially in electronics, pharma and cotton.
  • Prepare for possible Chinese retaliation: the commerce ministry has promised "necessary measures," and any export controls or tariffs would change costs and availability of Chinese inputs.
  • Monitor the September Trump-Xi meeting as the clearest near-term signal of whether the list expands again or enforcement is eased.
  • If you are a supplier not on the list, treat the expansion as a sales opportunity: buyers seeking continuity will need verifiable alternative sources.

Risk & Opportunity Assessment

Commercial RiskHigh43 companies lost US market access from Monday unless importers rebut the forced-labor presumption; affected sectors include electronics, pharma and cotton, forcing supply-chain reconfiguration.
Competitive RiskMediumUS buyers will shift orders to non-listed suppliers inside or outside China; listed firms face a competitive disadvantage until they can clear their status, while rivals gain market share.
Regulatory RiskCriticalThe DHS list operates under a law passed in late 2021 and has expanded from 144 to 187 companies; the burden of proof lies with importers, and further expansions are possible without new legislation.
Reputation RiskHighListed companies are formally associated with forced-labor allegations in Xinjiang, which can deter customers and partners even in markets outside the US.
Technology DisruptionMediumThe expansion touches electronics and pharmaceutical supply chains, raising the risk of input shortages or delays for products relying on listed Chinese suppliers.
Commercial OpportunityHighSuppliers not on the list, including producers outside China, can capture orders diverted from the newly banned companies; compliance and verification service providers also benefit.